Sailing: Swiss team Decouvertes-GeoMod wins the J/70 world championship in Monaco
MONACO, Oct. 24, 2022 (GLOBE NEWSWIRE) — The J/70 world championship, organized by the Yacht Club de Monaco, ends with the victory of the Swiss team Decouvertes-GeoMod. The crew, formed by Kilian Wagen, Gregeoire Siegwart, Luke Patience, David Hughes, Celia Wilson, finished on the top step of the podium followed by the Monegasque team Leonteq […]
Expereo appoints new Chief Human Resources Officer and Executive Board Member
AMSTERDAM, Oct. 24, 2022 (GLOBE NEWSWIRE) — Expereo, global provider of managed Internet and hybrid networks, SD-WAN and Cloud connectivity solutions, welcomes Victoria Marshall-Rice as its new Chief Human Resources Officer (CHRO) and Executive Board Member. This appointment expands upon Expereo’s ongoing commitment to sourcing and retaining the best talent to help organisations improve productivity […]
Luiss Rector Andrea Prencipe Received the Journal of Business Venturing’s Best Paper Award
Andrea Prencipe ROME, Oct. 24, 2022 (GLOBE NEWSWIRE) — Luiss Rector Andrea Prencipe received the Journal of Business Venturing’s Best Paper Award for the paper “The Language of Investments: How Language-Structure Influences Crowdfunding Investments.” The study was conducted with Professors Francesca Di Pietro, University Milano Bicocca, Francesca Masciarelli, University G. d’Annunzio Pescara, and Vangelis Souitaris, […]
Taconic Biosciences Launches First and Only Super Immunodeficient Mouse Models Lacking Residual Murine Fc Gamma Receptors, for Improved Antibody Therapy Assessment
FcResolv™ NOG Models Provide Greater Clarity and More Translatable Data RENSSELAER, N.Y., Oct. 24, 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has launched the FcResolv™ NOG portfolio, the first and only super immunodeficient mouse models lacking residual murine Fc gamma receptors (FcγRs) known to confound results […]
Innova Medical Group Announces Successful FDA Field Inspection Results and Formal Warning Letter Close-Out
PASADENA, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) — Innova Medical Group, Inc. (“Innova”), a global leader in antigen testing, announced that it has received from the United States Food and Drug Administration (“FDA”) a letter formally closing out the Warning Letter originally sent to the company on June 10, 2021. This close-out letter was received […]